

CLASSIFICATION: NEUROPEPTIDE / GASTROINTESTINAL MODULATOR
ACTIVE SUBSTANCE: VASOACTIVE INTESTINAL PEPTIDE (VIP)
FORM: LYOPHILIZED POWDER (2 ML VIAL x 6 MG)
ACTIVE HALF-LIFE: APPROX. 2–5 MINUTES (IN VIVO)
DOSAGE: 2–6 MG PER WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
VIP (Vasoactive Intestinal Peptide) is a 28-amino acid neuropeptide naturally produced in the gut, brain, and immune tissues. It is involved in a wide range of physiological processes, including smooth muscle relaxation, immune modulation, gastrointestinal function, and circadian rhythm regulation. This 6 mg (2 mL) vial by Peptide Hubs is a high-purity peptide formulation intended for research use only.
VIP is a pleiotropic signaling molecule with potent anti-inflammatory and immunomodulatory properties. It plays a critical role in regulating the enteric nervous system, pulmonary function, cardiovascular tone, and neuroprotection. According to published data on PubMed, VIP has been shown to suppress pro-inflammatory cytokines while enhancing regulatory T-cell activity, making it an attractive compound for inflammatory and autoimmune research.
Typical preclinical studies use VIP at 2–6 mg per week, divided into subcutaneous or intravenous injections. Due to its short half-life in vivo, some research protocols utilize stabilized formulations or frequent dosing. VIP is not bioavailable orally and should be handled with sterile technique under lab-controlled conditions.
Researchers commonly combine VIP with other anti-inflammatory or neuroactive peptides for synergistic benefit:
VIP has demonstrated a favorable safety profile in early human trials and preclinical models. It does not affect sex hormones or metabolic functions and shows no evidence of toxicity to liver, kidney, or cardiovascular systems. Because of its short half-life, dosing protocols may require precision timing or peptide stabilization methods.
Peptide Hubs provides fast and discreet USA domestic shipping for VIP 6 mg and all peptide research products. Every vial is manufactured in GMP-compliant labs and batch-tested for purity and sterility. VIP is a high-value research tool for gastrointestinal, neurological, and immune applications.
VIP is used in research focused on neuroimmune signaling, inflammation control, pulmonary health, and gastrointestinal motility.
VIP acts as both a neurotransmitter and hormone-like peptide, involved in smooth muscle relaxation, immune signaling, and circadian rhythm regulation.
Yes, VIP is often stacked with BPC-157, Selank, or SS-31 for advanced gut-brain axis, anti-inflammatory, and neuroprotective research.
VIP has shown good tolerability in early-phase research with no known toxicity in preclinical models. It is research-use only and not approved for therapeutic use.
Please log in to write VIP 6 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS